BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$85.60+0.56 (+0.66%)
Close on Nov 13, 2026Market cap $21.50BP/E –Yield –
BioNTech cash
Cash and short-term investments held at the end of each period.
BioNTech's cash was €7.68B at Dec 31, 2025. For fiscal 2025 it was €7.68B, down 21.4% from the year before. The highest annual figure on record is €13.88B in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €7.68B | -21.4% |
| FY2024 | Dec 31, 2024 | €9.76B | -16.3% |
| FY2023 | Dec 31, 2023 | €11.66B | -15.9% |
| FY2022 | Dec 31, 2022 | €13.88B | +719.7% |
| FY2021 | Dec 31, 2021 | €1.69B | +39.9% |
| FY2020 | Dec 31, 2020 | €1.21B | +133.1% |
| FY2019 | Dec 31, 2019 | €519.10M | +26.1% |
| FY2018 | Dec 31, 2018 | €411.50M | +139.1% |
| FY2017 | Dec 31, 2017 | €172.11M | -43.3% |
| FY2016 | Dec 31, 2016 | €303.68M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €7.68B | +353.4% |
| Q4 FY2024 | Dec 31, 2024 | €9.76B | +706.6% |
| Q4 FY2023 | Dec 31, 2023 | €11.66B | +2146.9% |
| Q4 FY2022 | Dec 31, 2022 | €13.88B | +3271.8% |
| Q4 FY2021 | Dec 31, 2021 | €1.69B | +883.5% |
| Q4 FY2020 | Dec 31, 2020 | €1.21B | +298.5% |
| Q4 FY2019 | Dec 31, 2019 | €519.10M | – |
| Q4 FY2018 | Dec 31, 2018 | €411.50M | – |
| Q4 FY2017 | Dec 31, 2017 | €172.11M | – |
| Q4 FY2016 | Dec 31, 2016 | €303.68M | – |
See a number that looks wrong?